Mr. Speaker, we are in process of consulting experts because it is important to take the best path forward. That does not mean that we have not taken any action. On the contrary, we are moving forward with concrete measures to make drugs more affordable for Canadians.
We have already seen positive results from the pan-Canadian pharmaceutical alliance, which saves Canadians $1 billion annually. We made major reforms to patented medicines regulations.
Yes, we created an advisory council on the implementation of national pharmacare to review our options. We will continue to work very hard for Canadians.